Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionPerkins Capital Management Inc
Latest Disclosed Ownership75,333 shares
Latest Disclosed Value $ 2,426,475
Perkins Capital Management Inc reports 0.13% decrease in ownership of 12V / Veracyte, Inc.

On April 23, 2026 - Perkins Capital Management Inc filed a 13F-HR form disclosing ownership of 75,333 shares of Veracyte, Inc. (DE:12V) valued at $2,003,858 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 75,433 shares of Veracyte, Inc.. This represents a change in shares of -0.13% during the quarter. The current value of the position is $3,053,246 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F VERACYTE COM 92337F107 75,333 -100 -0.13 2,426 -23.59 2.2741
2026-02-04 2025-12-31 13F VERACYTE COM 92337F107 75,433 -4,250 -5.33 3,176 16.09 2.5216
2025-10-31 2025-09-30 13F VERACYTE COM 92337F107 79,683 -2,267 -2.77 2,736 23.48 2.4109
2025-08-07 2025-06-30 13F Veracyte COM 92337F107 81,950 -4,600 -5.31 2,215 -13.68 2.2272
2025-05-07 2025-03-31 13F VERACYTE COM 92337F107 86,550 -3,650 -4.05 2,566 -28.14 2.7059
2025-02-11 2024-12-31 13F VERACYTE COM 92337F107 90,200 -3,730 -3.97 3,572 11.70 3.1687
2024-10-31 2024-09-30 13F VERACYTE COM 92337F107 93,930 -4,900 -4.96 3,197 159,750.00 2.9984
2024-08-09 2024-06-30 13F VERACYTE COM 92337F107 98,830 -17,150 -14.79 2 0.00 2.0182
2024-05-09 2024-03-31 13F VERACYTE COM 92337F107 115,980 -1,200 -1.02 3 -33.33 2.1431
2024-01-22 2023-12-31 13F VERACYTE COM 92337F107 117,180 -2,500 -2.09 3 50.00 2.7537
2023-11-02 2023-09-30 13F Veracyte COM 92337F107 119,680 -1,650 -1.36 3 -33.33 2.6489
2023-07-21 2023-06-30 13F VERACYTE COM 92337F107 121,330 -550 -0.45 3 50.00 2.6927
2023-05-09 2023-03-31 13F VERACYTE COM 92337F107 121,880 -1,150 -0.93 3 0.00 2.5627
2023-01-26 2022-12-31 13F VERACYTE COM 92337F107 123,030 -500 -0.40 3 -99.90 3.0826
2022-10-24 2022-09-30 13F VERACYTE COM 92337F107 123,530 -4,600 -3.59 2,051 -19.57 2.2950
2022-07-29 2022-06-30 13F VERACYTE COM 92337F107 128,130 5,150 4.19 2,550 -24.80 2.6396
2022-04-20 2022-03-31 13F VERACYTE COM 92337F107 122,980 -750 -0.61 3,391 -33.48 2.7799
2022-02-10 2021-12-31 13F VERACYTE COM 92337F107 123,730 -1,250 -1.00 5,098 -12.18 3.4416
2021-10-25 2021-09-30 13F VERACYTE COM 92337F107 124,980 0 0.00 5,805 16.17 3.5937
2021-07-28 2021-06-30 13F VERACYTE COM 92337F107 124,980 -1,500 -1.19 4,997 -26.49 2.8355
2021-04-28 2021-03-31 13F VERACYTE COM 92337F107 126,480 -600 -0.47 6,798 9.31 3.9312
2021-02-09 2020-12-31 13F VERACYTE COM 92337F107 127,080 -3,500 -2.68 6,219 46.57 4.0672
2020-10-28 2020-09-30 13F VERACYTE COM 92337F107 130,580 8,850 7.27 4,243 43.39 3.8970
2020-04-29 2020-03-31 13F VERACYTE COM 92337F107 121,730 -10,900 -8.22 2,959 -20.09 3.5746
2020-02-03 2019-12-31 13F VERACYTE COM 92337F107 132,630 -15,500 -10.46 3,703 4.16 3.3196
2019-10-23 2019-09-30 13F VERACYTE COM 92337F107 148,130 -21,250 -12.55 3,555 -26.38 3.0631
2019-08-09 2019-06-30 13F VERACYTE COM 92337F107 169,380 -28,060 -14.21 4,829 -2.25 3.3817
2019-04-22 2019-03-31 13F VERACYTE COM 92337F107 197,440 -11,265 -5.40 4,940 88.12 3.2526
2019-02-11 2018-12-31 13F VERACYTE COM 92337F107 208,705 -2,850 -1.35 2,626 30.00 2.0362
2018-10-22 2018-09-30 13F VERACYTE COM 92337F107 211,555 60,700 40.24 2,020 43.36 1.2127
2018-08-02 2018-06-30 13F VERACYTE COM 92337F107 150,855 131,475 678.41 1,409 1,204.63 1.0092
2018-04-23 2018-03-31 13F VERACYTE COM 92337F107 19,380 19,380 108 0.0972
2018-01-26 2017-12-31 13F VERACYTE COM 92337F107 0 -62,275 -100.00 0 -100.00
2017-10-31 2017-09-30 13F VERACYTE COM 92337F107 62,275 62,275 546 0.5720
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.